[Tocilizumab for refractory systemic juvenile idiopathic arthritis]. [electronic resource]
Producer: 20180323Description: 830-834 p. digitalISSN:- 0578-1310
- Antibodies, Monoclonal, Humanized -- adverse effects
- Arthritis, Juvenile -- drug therapy
- Blood Sedimentation
- C-Reactive Protein
- Case-Control Studies
- Child
- Child, Preschool
- Drug-Related Side Effects and Adverse Reactions
- Female
- Fever
- Humans
- Interleukin-6
- Male
- Prospective Studies
- Treatment Outcome
- Tumor Necrosis Factor-alpha
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.